http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201533241-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b2e295fd4a8e4cbc7a8f711f0447c4b |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate | 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83bf3c4fcd7654c367c5a218a600163a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb0bfa7d37945570be063d4c628c4c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee6714531aff2f48865aaa5339ea697e |
publicationDate | 2015-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-201533241-A |
titleOfInvention | Interfering ribonucleic acid for inhibiting interstitial metalloproteinase 1 (MMP1), pharmaceutical composition thereof and use thereof |
abstract | The present invention provides an interfering ribonucleic acid for inhibiting interstitial metalloproteinase 1 (MMP1) having 19 to 25 nucleotides, and the interfering ribonucleic acid nucleic acid is selected from SEQ ID NO. And a group consisting of substantially identical sequences of SEQ ID NO. 6, SEQ ID NO. 7 and SEQ ID NO. 8, SEQ ID NO. 9 and SEQ ID NO. 10, and combinations thereof; Interfering ribonucleic acid specifically binds to endogenous interstitial metalloproteinase-1 to achieve the effect of inhibiting interstitial metalloproteinase 1, and can be applied to a pharmaceutical composition for preventing or treating cancer cell metastasis or skin wrinkle resistance. |
priorityDate | 2014-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 756.